Testing of the Cancer Thriving and Surviving Breast Cancer Program
COSS
Co-creating and Testing the Reach and Effectiveness of an Integrated Peer-to-peer Self-management Program for Breast Cancer Survivors: a Pilot Study
1 other identifier
interventional
39
1 country
2
Brief Summary
The adjusted Cancer Thriving and Surviving Program (CTS) for women with breast cancer living in Switzerland (CTS-BC-CH) is a course of 7 weekly sessions of 2.5 - 3 hours led by trained peer-leaders (women with breast cancer experience). This pilot study aims to explore the reach of the CTS-BC-CH program (integrated into the clinical pathway) and to investigate its preliminary effectiveness with regard to Swiss breast cancer patients' self-efficacy and self-management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2017
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 12, 2017
CompletedFirst Submitted
Initial submission to the registry
May 1, 2018
CompletedFirst Posted
Study publicly available on registry
August 29, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2019
CompletedAugust 24, 2020
August 1, 2020
1.7 years
May 1, 2018
August 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Reach of intervention assessed by ratio of eligible patients vs. participating patients
21 weeks after baseline
Changes in self-management skills assessed by heiQ
Assessed by the Health Education Impact Questionnaire (heiQ)
Change from baseline to 20 weeks after baseline
Secondary Outcomes (5)
Change in patient-reported self-efficacy assessed by SES6G
Change from baseline to 20 weeks after baseline
Change in patient-reported health literacy assessed by HLS-EU-Q6
Change from baseline to 20 weeks after baseline
Change in patient-reported symptom burden assessed by BCPT Symptom Scales
Change from baseline to 20 weeks after baseline
Change in patient-reported health service navigation assessed by heiQ
Change from baseline to 20 weeks after baseline
Change in nurse-reported self-efficacy and self-management support practices assessed by SEPSS
Change from baseline to 30 weeks after baseline
Study Arms (2)
Usual care
NO INTERVENTIONUsual follow-up care offered in the breast centers after primary treatment by breast care team (e. g. breast care nurses, gynaecologist, oncologist, psychologist).
Usual care and CTS-BC-CH
EXPERIMENTALCTS-BC-CH as 7 weekly group session à 2.5 - 3 hours.
Interventions
CTS-BC-CH is a standardized program with 7 weekly group sessions (2.5. to 3 hours). The CTS-BC-CH focuses on building skills, sharing experiences, and support among the participants. Program elements are: Brainstorming, action plan formulation, action plan feedback, problem solving, and decision making.
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Manuela Eicherlead
- Swiss Cancer Leaguecollaborator
- Lindenhofgruppe AGcollaborator
Study Sites (2)
University Hospital Basel
Basel, 4031, Switzerland
University Inselspital Bern
Bern, 3010, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Manuela Eicher, Prof. Dr.
Institute of Higher Education and Reserach in Health Care - IUFRS University of Lausanne and University Hospital of Lausanne
- STUDY DIRECTOR
Joerg Haselbeck, Dr.
Swiss Cancer League Berne; Formely: Careum Stiftung, Kompetenzzentrum Patientenbildung
- STUDY CHAIR
Karin Ribi, Dr. phil.
International Breast Cancer Study Group (IBCSG)
- STUDY CHAIR
Corinne Urech, Dr. phil.
University Hospital, Basel, Switzerland
- STUDY CHAIR
Karin Holm
Patient Advocats for Cancer Reserach and Treamtment (Association PARCT)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 1, 2018
First Posted
August 29, 2018
Study Start
December 12, 2017
Primary Completion
August 15, 2019
Study Completion
August 15, 2019
Last Updated
August 24, 2020
Record last verified: 2020-08